Navigation Links
Third European Novel Food Approval Received by Tahitian Noni International
Date:4/28/2010

Outnumbered only by Unilever, TNI and Danone share the leading position in the European Union’s “Novel Foods” category

Provo, UT (Vocus) April 28, 2010 -- Tahitian Noni International (TNI) received the company’s third Novel Food approval from the European Commission on Food Safety. Now, not only do noni juice and noni leaf have Novel Food approval, but also noni concentrates and noni puree have authorization to be sold within the European Union. In terms of the total number of Novel Food approvals, Tahitian Noni International shares an equal number with Danone and is outnumbered only by the five individual approvals granted to the Unilever Group.

Committed to Science and Quality from Day One
Approval procedures for Novel Foods take time, money, and require significant scientific research assuring the safety of the product in question. It is not uncommon for an application to take five years or more being reviewed, before approval is granted.

Kevin Asay, Tahitian Noni International’s Managing Director in charge of Regulatory Affairs and Quality Assurance, says: “14 years after the founding of our company, we are in a position to compete with Danone in the category of approved Novel Food applications. We take pride in this achievement and are confident that it stems from our commitment to science and quality from day one.”

Noni is now a Full-Fledged Novel Food
With this third approval, Tahitian Noni International now holds Novel Food approval for all food categories relevant to their wide variety of products. In 2003, the first approval was issued for the use of noni juice as a novel food ingredient in Tahitian Noni™ Original, then marketed as Tahitian Noni™ Juice in Europe. This approval was followed in 2008 by the authorization of noni leaves as a novel food ingredient for the preparation of other products, including tea. This latest approval now gives Tahitian Noni International the ability to use noni concentrates and noni puree in products as well.

Currently, Tahitian Noni International is focused on the worldwide product launch of its new product line of Tahitian Noni® Bioactive Beverages™ introduced in the USA at the end of February 2010. A graduated launch in Europe is scheduled to start at the end of May 2010.

About the Company
Tahitian Noni International is a global, research-driven bioactive products company that was the first to introduce the health benefits of the noni plant—a bioactive-rich, adaptogenic plant, containing iridoid compounds—to the world outside of Tahiti. Tahitian Noni International is the leader in the discovery, development, manufacturing, and marketing of noni-based bioactive products including beverages, beauty, and weight loss lines. Tahitian Noni International has a presence in over 70 markets worldwide, and is the world-wide leader in bioactive beverages.

Contact:
Andre Peterson
Director, Public Relations
(801) 234-1401

# # #

Read the full story at http://www.prweb.com/releases/2010/Novel_food_approval/prweb3934514.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related medicine news :

1. SIS Rules-Based Charging Solution Successfully Peer Reviewed by HFMA for Third Consecutive Year
2. Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the Third Quarter and First Nine Months of Fiscal Year 2010
3. Anthem Blue Cross Wins Third Largest Medicaid Managed Care Contract Renewal in the Country
4. Tipping Point Community Announces $1 Million Gift at Third Annual Awards Breakfast
5. China Nepstar Chain Drugstore Reports 92.1% Year-on-Year Increase in Operating Income for Third Quarter 2009
6. Almost two-thirds of pregnant women believe they are regularly exposed to physical risk at work
7. Two-Thirds of American Teens Need More Shut-Eye
8. Study Finds More Than One Third of Parents Experience Traumatic Stress One Month After Childs Injury
9. New Program Provides COBRA Relief for Third Party Administrators
10. Chindex International, Inc. Reports Third Quarter Fiscal Year 2010 Financial Results
11. New Study Shows Nearly One Third of Overweight Adolescents See Themselves as Underweight or About Right
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Third European Novel Food Approval Received by Tahitian Noni International 
(Date:2/23/2017)... ... February 23, 2017 , ... The American Cleft Palate-Craniofacial Association (ACPA) ... Meeting. KLS is a longtime supporter of the event. , "We are pleased ... Sponsor," said Dr. Bob Havlik, 2017 ACPA President. "KLS Martin has a long track ...
(Date:2/23/2017)... ... February 23, 2017 , ... On April ... diverse symposium on “Doping in Sport: How the Culture Might Change,” ... Hampton LLP. The symposium will be held at Pepperdine University in Malibu, California. ...
(Date:2/23/2017)... ... February 23, 2017 , ... ... and community for those in the fight against cancer, has produced a seminal ... success. HRA will release top-line findings in a webinar, Defining Compassionate Care ...
(Date:2/23/2017)... York (PRWEB) , ... February 23, 2017 , ... Curemark, ... the safety and efficacy of CM-AT in children aged 3-8 with Autism, is now ... clinical sites already enrolling children across the United States. , “There are currently ...
(Date:2/22/2017)... ... February 22, 2017 , ... Our high-octane society demands ... the sharpest brain. , Power On, a mental performance enhancer from Modus Nutrition, ... brain. Each capsule contains Cognizin® Citicoline, a branded form of the brain health ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... 23. Februar 2017 LG Innotek hat heute ... Die Sterilisationsleistung beträgt das 1,5-fache des 45-mW-Moduls der Konkurrenz. ... Bereich zwischen 200 und 280 nm und eignet sich damit ... es ihre DNA zerstört. Das Produkt von LG Innotek ... ...
(Date:2/23/2017)... and Markets has announced the addition of the "Menopause Drugs Price ... ... Analysis and Strategies - 2016, provides drug pricing data and benchmarks in ... What are the key drugs marketed for Menopause ... market? What are the unit prices and annual treatment ...
(Date:2/23/2017)... Calif. , Feb. 23, 2017 ... company focused on the development and commercialization of ... pain, announced that it will release fourth quarter ... Thursday, March 2nd, 2017. AcelRx management will host ... Time (1:30 p.m. Pacific Time) on March 2 ...
Breaking Medicine Technology: